Ketanserin 是一种特异性的5-HT2A 5-羟色胺受体拮抗剂,作用于大鼠和人5-HT2A,Ki为2.5 nM。
Ketanserin is specific 5-HT2A serotonin receptor antagonist with a Ki of 2.5 nM for rat and human 5-HT2A.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Van Nueten JM, et al. J Pharmacol Exp Ther, 1981, 218(1), 217-230.
[2] Razzaque, Z., et al. 1995. Eur. J. Pharmacol. 283: 199-206.
[3] Zgombick, J.M., et al. 1995. Eur. J. Pharmacol. 291: 9-15.
[4] Leysen, J.E., et al. 1982. Mol. Pharmacol. 21: 301-314.
分子式 C22H22FN3O3 |
分子量 395.43 |
CAS号 74050-98-9 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 2 mg/mL |
Water <1 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT00557219 | Acute Renal Failure | Drug: fenoldopam (Corlopam)|Drug: placebo|Drug: ketanserin (Sufrexal) | Medical University of Gdansk | Phase 3 | 2008-04-01 | 2016-11-14 |
NCT02632877 | Diabetic Foot Ulcer | Drug: Pirfenidone with MODD|Drug: Ketanserin | University of Guadalajara|Cell Pharma, SA de CV | Phase 1|Phase 2 | 2014-01-01 | 2015-12-14 |
NCT01329887 | Severe Sepsis|Septic Shock | Drug: ketanserin | Medical Centre Leeuwarden | Phase 3 | 2011-03-01 | 2014-05-08 |
NCT02451072 | Healthy | Drug: Placebo|Drug: LSD|Drug: Ketanserin | Psychiatric University Hospital, Zurich | 2015-03-01 | 2016-01-29 | |
NCT01778686 | Healthy | Drug: Citalopram and Pindolol|Other: Placebo|Dietary Supplement: Acute tryptophan depletion | Gitte Moos Knudsen|Rigshospitalet, Denmark | 2013-01-01 | 2015-10-28 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们